- $2.66m
- -$0.46m
- $22.99m
- 65
- 98
- 63
- 89
Annual balance sheet for Trucept, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2011 December 31st | 2012 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.132 | 0.546 | 0.123 | 2.29 | 3.12 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.37 | 2.48 | 4.98 | 3.64 | 3.25 |
| Prepaid Expenses | |||||
| Total Current Assets | 4.55 | 3.03 | 5.21 | 6.72 | 7.03 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.055 | 0.033 | 0.029 | 0.21 | 0.173 |
| Net Goodwill | |||||
| Other Long Term Assets | |||||
| Total Assets | 8.52 | 8.17 | 6.01 | 7.71 | 7.98 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15.4 | 22.9 | 6.71 | 7.35 | 6.35 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.4 | 22.9 | 7.69 | 7.5 | 6.47 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -6.9 | -14.8 | -1.68 | 0.202 | 1.51 |
| Total Liabilities & Shareholders' Equity | 8.52 | 8.17 | 6.01 | 7.71 | 7.98 |
| Total Common Shares Outstanding |